Latest News Archive

Please select Category, Year, and then Month to display items

Prof Abdon Atangana receives one of Cameroon’s highest national honours

09 October 2025 | Story Martinette Brits | Photo Supplied

Prof Abon Atangana — Prof Abdon Atangana, leading applied mathematics scholar at the University of the Free State, who has been awarded the Chevalier de l’Ordre de la Valeur by the President of Cameroon in recognition of his outstanding contributions to science and international academic engagement.

In recognition of his exceptional contributions to science and for promoting a positive image of Cameroon internationally, Prof Abdon Atangana, a leading professor of applied mathematics at the University of the Free State (UFS), has been awarded one of the country’s highest national honours by His Excellency President Paul Biya.

Prof Atangana, who is based in the UFS Faculty of Natural and Agricultural Sciences, was formally informed by the Cameroon High Commission in Pretoria that the President had decided to confer upon him the title Chevalier de l’Ordre de la Valeur (Knight of the Order of Valour).

“I am deeply honoured by this recognition and grateful to the High Commission for conveying the news,” said Prof Atangana.

The Ordre de la Valeur is one of Cameroon’s principal national distinctions, awarded to individuals who have rendered distinguished service or made significant contributions in fields such as science, public service, the arts, or international representation.

“The title Chevalier denotes formal national recognition by the President,” Prof Atangana explained. “It affirms the value of my work and encourages continued research, mentorship, and international collaboration.”

A career of global impact and recognition

Prof Atangana’s career is marked by both academic excellence and international engagement. He has consistently ranked among the top 1-2% of applied mathematicians worldwide, according to Stanford University’s global list. His achievements include being the first African mathematician under 40 to become a Fellow of the African Academy of Sciences Affiliates, receiving the UNESCO–TWAS Mohammad A. Hamdan Prize, the AL Fozan UNESCO Award for STEM, and the African Genius Award.

He also serves as Chair of the African Mathematical Union Commission on Research and Innovation and is the first President of the African Society for Industrial and Applied Mathematics (ASIAM).

In a historic milestone for African mathematics, Prof Atangana represented Africa for the first time at the Board Meeting of the International Council for Industrial and Applied Mathematics (ICIAM) in Vietnam in 2025. This prestigious gathering brings together presidents of national and international applied mathematics societies, including the President of the International Mathematical Union, and marks a significant recognition of his leadership on the global stage.

“Being named Chevalier de l’Ordre de la Valeur recognises years of sustained work and the support of many colleagues and students,” he said. “Professionally, it is an important encouragement to continue my research, mentoring, and international engagement.”

Beyond awards, Prof Atangana has actively promoted Cameroon’s profile in the international scientific community. He has built high-impact research collaborations, supervised and mentored students from Cameroon and across Africa, presented at international conferences, and published research connecting African science with global knowledge networks.

Advancing science through the UFS and international collaboration

Much of the work recognised by this honour has been conducted at the University of the Free State.

“The recognition reflects the outcomes of work done at the UFS and signals the university’s contribution to advancing regional research capacity and international partnership,” Prof Atangana said.

His academic engagement in South Africa has enabled him to act as a bridge between institutions, fostering joint research, student exchanges, and collaboration across continents. These activities demonstrate the power of academic engagement in promoting scientific excellence and strengthening international networks.

Looking ahead, Prof Atangana plans to leverage this recognition to expand collaborative research projects, create more opportunities for student exchanges and mentorship, and advance interdisciplinary initiatives addressing regional and global challenges.

“I will continue to promote the value of academic engagement in service of shared scientific and societal goals,” he said. “This recognition will inspire me to strengthen collaborative networks, pursue joint research initiatives, and mentor the next generation of researchers.”

Details of the official medal award ceremony will be shared by the Cameroon High Commission in due course.

News Archive

Nuclear Medicine on the forefront of cancer research

2017-07-10

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma. The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept